S. aureus is the single most common cause of both systemic and local infections in the drug user population. Despite its recognized importance as a pathogen, surprisingly little is known about factors that predispose drug users to these overwhelming infections. Drug users appear to have a high staphylococcal colonization rate and are believed to become infected with the strains they carry. This proposal will integrate a molecular, epidemiologic analysis of staphylococcal colonization and subsequent infection in this high risk population with a biologic investigation of the pathogenesis of this process. This study will be performed using a cohort of drug users presently followed at the Montefiore Substance Abuse Treatment Program. Examining the basis for staphylococcal colonization and the patterns of carriage in a well defined cohort, will provide an ideal model for understanding the epidemiology and biology of these infections.
Our specific aims i nclude the following. 1. Define the demographic features of the drug user population that may influence staphylococcal colonization and infection. These include: 1) the nature and frequency of drug use; 2) the role of sex, age, ethnicity and race; 3) the contribution of HIV infection and disease; and 4) the impact of other medical problems, antibiotic use or intercurrent hospitalization. 2. Compare staphylococcal isolates collected from the drug user cohort and the hospitalized drug users. The DNA profiles of these strains will be determined. The nature and persistence of colonizing strains will be defined, and compared with those causing infection. Linkage of particular colonizing or disease-producing strains with antibiotic resistance or other virulence determinants will be pursued. 3. Examine the biologic features that influence colonization in vitro. The biology of S. aureus nasal colonization will be investigated using the staphylococcal strains collected from controls and the drug user groups. The studies will examine both strain and host specific features that may influence colonization or infection. The increasing problem of multidrug-resistant staphylococci has added new urgency to the need for alternative approaches to the prevention of these life-threatening diseases. In order to develop these alternatives, we must first understand the strain and host determinants that play a role in this process.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009656-02
Application #
2856548
Study Section
Human Development Research Subcommittee (NIDA)
Project Start
1998-01-01
Project End
2002-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Montefiore Medical Center (Bronx, NY)
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10467
Lee, Mei-Ho; Arrecubieta, Carlos; Martin, Francis J et al. (2010) A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis 201:508-15
Keene, Adam; Vavagiakis, Peter; Lee, Mei-Ho et al. (2005) Staphylococcus aureus colonization and the risk of infection in critically ill patients. Infect Control Hosp Epidemiol 26:622-8
Cespedes, Christian; Said-Salim, Battouli; Miller, Maureen et al. (2005) The clonality of Staphylococcus aureus nasal carriage. J Infect Dis 191:444-52
Miller, M; Cespedes, C; Vavagiakis, P et al. (2003) Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis 22:463-9
Quagliarello, Bianca; Cespedes, Christian; Miller, Maureen et al. (2002) Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis 35:671-7
Cespedes, Christian; Miller, Maureen; Quagliarello, Bianca et al. (2002) Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol 40:2594-7
Lowy, Franklin D; Miller, Maureen (2002) New methods to investigate infectious disease transmission and pathogenesis--Staphylococcus aureus disease in drug users. Lancet Infect Dis 2:605-12
Peacock, S J; de Silva, I; Lowy, F D (2001) What determines nasal carriage of Staphylococcus aureus? Trends Microbiol 9:605-10
Lowy, F D (2000) Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol 8:341-3
McGahee, W; Lowy, F D (2000) Staphylococcal infections in the intensive care unit. Semin Respir Infect 15:308-13

Showing the most recent 10 out of 12 publications